+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as guidance for prophylaxis and treatment of bleeding and re-bleeding? Yes!



Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as guidance for prophylaxis and treatment of bleeding and re-bleeding? Yes!



European Journal of Internal Medicine 22(1): 1-4



Portal hypertension is key to the natural history of cirrhosis. The standard way to assess portal hypertension is the hepatic venous pressure gradient (HVPG). HVPG has been convincingly shown to be a strong predictor of variceal bleeding and survival. In addition, it has been shown to predict other portal hypertension-related clinical events, to include fluid retention and hepatic encephalopathy. Finally, HVPG is the only suitable tool to assess the response of portal hypertension to medical treatment. Thus, although not necessarily easy to measure, HVPG provides the clinician with information which is prognostically crucial and otherwise unobtainable.

(PDF emailed within 0-6 h: $19.90)

Accession: 055765968

Download citation: RISBibTeXText

PMID: 21238883

DOI: 10.1016/j.ejim.2010.08.009


Related references

Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as a guide for prophylaxis and therapy of bleeding and rebleeding? No. European Journal of Internal Medicine 22(1): 5-7, 2011

Hepatic venous pressure gradient in cirrhosis: role in variceal bleeding, non-bleeding complications and outcome. Asian Journal of Surgery 29(3): 113-119, 2006

Hepatic venous pressure gradient hvpg as a predictor of survival in patients with cirrhosis. Hepatology 12(4 PART 2): 850, 1990

Portal venous pressure and portal venous pressure gradient are similar in patients with refractory ascites and recurrent variceal bleeding. Gastroenterology 114(4 PART 2): A1361, April 15, 1998

Comparison of the effects of propranolol prop and placebo pla on variceal pressure vp and hepatic venous pressure gradient hvpg in cirrhosis. Journal of Hepatology 13(SUPPL 2): S28, 1991

Hepatic venous pressure gradient measurement in patients with liver cirrhosis: a correlation with disease severity and variceal bleeding. Medicina 45(1): 8-13, 2009

Monitoring hepatic venous pressure gradient in patients on beta blocker therapy for primary prophylaxis of variceal bleeding is cost-effective. Gastroenterology 112(4 SUPPL ): A1355, 1997

Cost-effectiveness of hepatic venous pressure gradient measurements for prophylaxis of variceal re-bleeding. Alimentary Pharmacology & Therapeutics 19(5): 571-581, 2004

A computational model of the hepatic circulation applied to analyze the sensitivity of hepatic venous pressure gradient (HVPG) in liver cirrhosis. Journal of Biomechanics 65: 23-31, 2017

Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and child's status. Digestive Diseases and Sciences 51(12): 2264-2269, 2006

Relationships between the time-course of hepatic venous pressure gradient and the response to endoscopic treatment of varices in cirrhotic patients with acute variceal bleeding. Hepatology 34(4 Pt 2): 535A, 2001

Comparison of portal vein velocity and the hepatic venous pressure gradient in assessing the acute portal hemodynamic response to propranolol in patients with cirrhosis. American Journal of Gastroenterology 95(10): 2905-2909, 2000

Measurement of hepatic venous pressure gradient in patients with active variceal bleeding. Hepatology 41(2): 406-7; Author Reply 407, 2005

Is portal hypertensive gastropathy related to hepatic venous pressure gradient in patients with cirrhosis?. Journal of Hepatology 30(SUPPL 1): 191, 1999

Should we routinely measure HVPG to assess response of primary prophylaxis in patients with cirrhosis? A decision analytic study. Hepatology 34(4 Pt 2): 534A, 2001